Back to results
US 2019/0169255 A1Published application
Il-2 muteins and uses thereof
AssigneePandion Therapeutics, Inc.
InventorsNathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
Life of this patent
Estimating the term…
Abstract
The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
Claims2
A protein consisting of an amino acid sequence of SEQ ID NO:
- 39.
Dependencies are inferred from the claim text.